covid
Buscar en
Progresos de Obstetricia y Ginecología
Toda la web
Inicio Progresos de Obstetricia y Ginecología Defectos del tubo neural y gen cistationina β-sintasa
Información de la revista
Vol. 46. Núm. 11.
Páginas 495-501 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 46. Núm. 11.
Páginas 495-501 (enero 2003)
Acceso a texto completo
Defectos del tubo neural y gen cistationina β-sintasa
Neural tube defects and the cystathionine β-synthase gene
Visitas
3943
J.I. Gutiérrez-Revillaa,
Autor para correspondencia
joseignaciogutierrez@redfarma.org

Correspondencia: Servicio de Bioquímica Clínica. Sección de Genética. Hospital Universitario Miguel Servet. P.° Isabel La Católica, 1–3. 50009 Zaragoza. España
, F. Pérez-Hernándezb, M. Tamparillasa
a Servicio de Bioquímica Clínica. Sección de Genética. Hospital Universitario Miguel Servet. Zaragoza
b Farmacéutica de Atención Primaria. Gerencia Santander-Laredo. Santander. España
Este artículo ha recibido
Información del artículo
Resumen
Objetivo

Identificar alteraciones en genes relacionados con el metabolismo del folato como el gen cistationina β-sintasa, con el fin de estudiar su posible implicacion en la aparicion de defectos del tubo neural.

Material y métodos

En 27 pacientes con defectos del tubo neural, 28 madres de pacientes, 23 hermanos de pacientes sin defectos del tubo neural y 159 controles sanos, se han estudiado los polimorfismos T833C y 844ins68 dentro del gen cistationina β-sintasa y su relacion con la homocisteina.

Resultados

La prevalencia de T833C y 844ins68 entre los grupos estudiados es la misma (p = 0,861). Tampoco se han podido establecer diferencias significativas en las concentraciones de homocisteina (p = 0,429), folato (p = 0,886), vitamina B12 (p = 0,934) y folato intraeritrocitario (p = 0,618) entre individuos homocigotos o heterocigotos para el polimorfismo T833C y 844ins68 al compararlos con individuos con genotipo normal.

Conclusiones

No existe una evidencia directa entre T833C y 844ins68 del gen cistationina β- sintasa y el riesgo de defectos del tubo neural, aunque es necesaria la realizacion de nuevos estudios confirmativos.

Palabras Clave:
Cistationina β-sintasa
Homocisteina
Folato
Vitamina B12
Folato intracelular
Summary
Objective

To identify alterations in genes related with folate metabolism such as the cystathionine β-synthase (CBS) gene in order to study their possible involvement in the development of neural tube defects (NTD).

Subjects and methods

The study group consisted of 27 NTD patients, 28 mothers of children with NTD, 23 siblings of patients without NTD and 159 healthy controls. The effect of one silent polymorphism (T833C) and 68-bp insertion (844ins68) of the CBS gene on plasma homocysteine (tHcy) levels was evaluated.

Results

No difference was found between the groups in the prevalence of T833C and 844ins68 (p = 0.861). No significant differences were found in concentrations of tHcy (p = 0.429), folate (p = 0.886), vitamin B12 (p = 0.934) or intracellular folate (p = 0.618) between individuals who where heterozygous or homozygous for the T833C polymorphism and individuals carrying the 68-bp insertion compared with individuals with the wild type genotype.

Conclusions

The results of this study provide no direct evidence of a link between T833C and 844ins68 of the CBS gene and the folate-related risk of NTD, although further studies should be performed to confirm this result.

Key Words:
Cystathionine β-synthase
Homocysteine
Folate
Vitamin B12
Intracellular folate
El Texto completo está disponible en PDF
Bibliografía
[1.]
L.D. Botto, C.A. Moore, M.J. Khoury, J.D. Erickson.
Neural tube defects.
N Engl J Med, 341 (1999), pp. 1509-1519
[2.]
B.H. Lee, H. Cheong, Y.S. Shin, B.K. Cho, K.C. Wang.
The effect of C677T mutation of methylenetetrahydrofolate reductase gene and plasma folate level on hyperhomocysteinemia in patients with meningomyelocele.
Child Nerv Syst, 16 (2000), pp. 559-563
[3.]
A.E. Czeizel, I. Dudas.
Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation.
N Engl J Med, 327 (1992), pp. 1832-1835
[4.]
M.J. Gos, A. Szpecht-Potocka.
Genetic basis of neural tube defects. II. Genes correlated with folate and methionine metabolism.
J Appl Genet, 43 (2002), pp. 511-524
[5.]
S.H. Mudd, H.L. Levy, F. Skovby.
Disorders of transsulfuration.
The metabolic and molecular basis of inherited disease, pp. 1279-1327
[6.]
J.P. Kraus, J. Oliveriusova, J. Sokolova.
The human cystathinine beta-synthase (CBS) gene: complete sequence, alternative splicing, and polymorphisms.
Genomics, 52 (1998), pp. 312-324
[7.]
M.P. Sperandeo, R. De Franchis, G. Andria, G. Sebastio.
A 68-bp insertion found in a homocystinuric patient is a common variant and is skipped by alternative splicing of the cystathionine â-synthase mRNA.
Am J Hum Genet, 59 (1996), pp. 1391-1393
[8.]
M.Y. Tsai, M. Bignell, K. Schwichtenberg, N.Q. Hanson.
High prevalence of a mutation in the cystathionine â-synthase gene.
Am J Hum Genet, 59 (1996), pp. 1262-1267
[9.]
L.A.J. Kluijmans, G.H.J. Boers, F.J.M. Tribels, H.M.A. Van Lith-Zanders, L.P.W.J. Van den Heuvel, H.J. Blom.
A common 844ins68 insertion variant in the cistathionine beta-synthase gene.
Biochem Mol Med, 62 (1997), pp. 23-25
[10.]
D. Ramsbotom, J.M. Scott, A. Molloy.
Are common mutations of cystathionine beta-synthase involved in the etiology of neural tube defects?.
Clin Genet, 51 (1997), pp. 39-42
[11.]
D.E. Wilchen, X.L. Wang.
Relevance to spina bifida of mutated methylene tetrahydrofolate reductase.
Lancet, 347 (1996), pp. 340
[12.]
M.Y. Tsai, M. Bignell, F. Yang, B.G. Welge, K.J. Graham, N.Q. Hanson.
Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine â-synthase and A2756G of methionine synthase, with lowered plasma homocysteine levels.
Atherosclerosis, 149 (2000), pp. 131-137
[13.]
M.T. Shipchandler, E.G. Moore.
Rapid, fully automated measurement of plasma homocysteine with the Abbot Imx analyzer.
Clin Chem, 41 (1995), pp. 991-998
[14.]
L.A.J. Kluijtmans, L.P. Van den Heuvel, G.H. Boers, P. Frosst, E.M. Stevens, B.A. Van Oost, et al.
Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylene tetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease.
Am J Hum Genet, 58 (1996), pp. 35-41
[15.]
R.P. Steegers-Theunissen, G.H. Boers, F.J. Tribels, T.K. Eskes.
Neural tube defects and derangement of homocysteine metabolism.
N Engl J Med, 324 (1991), pp. 199-200
[16.]
R.P. Steegers-Theunissen, G.H. Boers, H.J. Blom, F.J. Tribels, T.K. Eskes.
Hyperhomocysteinemia and recurrent spontaneous abortion or abruptio placentae.
Lancet, 339 (1992), pp. 1122-1123
[17.]
M.C. Koch, K. Stegman, A. Ziegler, B. Schroeter, A. Ermert.
Evaluation of the MTHFR C677T allele and the MTHFR gene locus in a German spina bifida population.
Eur J Pediatr, 157 (1998), pp. 487-492
[18.]
M.Y. Tsai, M. Bignell, F. Yang, B.G. Welge, K.J. Graham, N.Q. Hanson.
Polygenic influence on plasma homoysteine: association of two prevalent mutations, the 844ins68 of cystathionine â-synthase and A2756G of methionine synthase, with lowered plasma homocysteine levels.
Atherosclerosis, 149 (2000), pp. 131-137
[19.]
R. Franco, F. Maffei, D. Lourenco, C. Piccinato, V. Morelli, I. Thomazini, et al.
The frequency of 844ins68 mutation in the cystathionine beta-synthase gene is not increased in patients with venous thrombosis.
Haematologica, 83 (1998), pp. 1006-1008
[20.]
M.Y. Tsai, F. Yang, M. Bignell, O. Aras, N.Q. Hanson.
Relation between plasma homocysteine concentration, the 844ins68 variant of the cystathionine beta-synthase gene, and pyridoxal-5'-phosphate concentration.
Mol Genet Metab, 67 (1999), pp. 352-356
[21.]
D. Ramsbottom, J.M. Scott, A. Molloy, D.G. Weir, P.N. Kirke, J.L. Mills, et al.
Are common mutations of cystathionine beta-synthase involved in the etiology of neural tube defects?.
Clin Genet, 51 (1997), pp. 39-42
[22.]
K. Morrison, C. Papapetrou, F.A. Hol, E.C. Mariman, S.A. Lynch, J. Burn, et al.
Susceptibility to spina bifida; an association study of five candidate genes.
Ann Hum Genet, 62 (1998), pp. 379-396
Copyright © 2003. Sociedad Española de Ginecología y Obstetricia
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos